Andrew S. Rappaport's most recent trade in Olema Pharmaceuticals Inc was a trade of 35,868 Common Stock done at an average price of $0.4 . Disclosure was reported to the exchange on Nov. 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Olema Pharma Inc | Andrew S. Rappaport | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share. | 21 Nov 2025 | 35,868 | 35,868 | - | 0.4 | 13,989 | Common Stock |
| Olema Pharma Inc | Andrew S. Rappaport | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 35,868 | 0 | - | - | Stock Option (right to buy) | |
| Olema Pharma Inc | Andrew S. Rappaport | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 21 Nov 2025 | 35,868 | 0 | - | 0 | Common Stock | |
| Olema Pharma Inc | Andrew S. Rappaport | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 24,150 | 24,150 | - | - | Stock Option (right to buy) | |
| Olema Pharma Inc | Andrew S. Rappaport | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 23,000 | 23,000 | - | - | Stock Option (right to buy) | |
| Olema Pharma Inc | Andrew S. Rappaport | Director | Other type of transaction at price $ 0.00 per share. | 05 Mar 2024 | 481,014 | 0 | - | 0 | Common Stock | |
| Olema Pharma Inc | Andrew S. Rappaport | Director | Other type of transaction at price $ 0.00 per share. | 05 Mar 2024 | 385,965 | 385,965 | - | 0 | Common Stock | |
| Olema Pharma Inc | Andrew S. Rappaport | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 21,520 | 21,520 | - | - | Stock Option (right to buy) | |
| Olema Pharma Inc | Andrew S. Rappaport | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 21,520 | 21,520 | - | - | Stock Option (right to buy) | |
| Olema Pharma Inc | Andrew S. Rappaport | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 21,520 | 21,520 | - | - | Stock Option (right to buy) |